1. Home
  2. CYTK vs CTRE Comparison

CYTK vs CTRE Comparison

Compare CYTK & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$56.27

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

N/A

Current Price

$38.09

Market Cap

8.6B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
CTRE
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.6B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
CYTK
CTRE
Price
$56.27
$38.09
Analyst Decision
Buy
Strong Buy
Analyst Count
22
13
Target Price
★ $109.42
$43.54
AVG Volume (30 Days)
1.9M
★ 2.9M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
★ 4.09%
EPS Growth
N/A
★ 96.25
EPS
N/A
★ 1.08
Revenue
$13,368,000.00
★ $476,393,000.00
Revenue This Year
$87.17
$27.95
Revenue Next Year
$170.90
$33.58
P/E Ratio
★ N/A
$35.24
Revenue Growth
N/A
★ 60.79
52 Week Low
$53.58
$34.74
52 Week High
$88.31
$43.62

Technical Indicators

Market Signals
Indicator
CYTK
CTRE
Relative Strength Index (RSI) 38.80 56.16
Support Level N/A $35.65
Resistance Level $66.62 $40.34
Average True Range (ATR) 2.69 0.88
MACD -0.24 0.22
Stochastic Oscillator 24.29 76.84

Price Performance

Historical Comparison
CYTK
CTRE

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

Share on Social Networks: